Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=abd976c2-3a19-4789-a0ff-c90aafffa534&Preview=1 Date 12/3/2012 Company Name Marginize Mailing Address 100 Benefitfocus Way Boston, MA 02115 Company Description Marginize enables real conversations in the margin of any website! Website http://www.marginize.com Transaction Type Venture Equity Transaction Amount $309,994 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms Venture Investor … Continue reading “Marginize Garners $309,994 New Funding”
Category: Boston
Maximizing Value and Minimizing Risk with Remote Workers
For me, being able to work remotely is one of the greatest gifts of the information age. It allowed me to help raise my daughters in the ’80s and ’90s, live almost four hours from a major airport, and now I’m able to visit my granddaughters in Chicago at the drop of a hat, all … Continue reading “Maximizing Value and Minimizing Risk with Remote Workers”
Five Characteristics VCs Look For in a Marketing Exec
Venture capitalists are paying more attention to the structure of the marketing teams they invest in. Why? Because marketing plays an increasingly influential role in the success of their portfolio companies. To ensure that the marketing department can generate the kind of leads that drive sales, they want to see a particular profile in a … Continue reading “Five Characteristics VCs Look For in a Marketing Exec”
East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More
Big Pharma expanded its love affair with biotech startups this week, making investments and doing deals, while Cambridge continued to be the place to do business for emerging life sciences companies. New York, on the other hand, is hosting an awful lot of clinical trials. —On Thursday, Rib-X Pharmaceuticals of New Haven, CT, closed the … Continue reading “East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More”
Photo Books from Blurb: A High-Tech Gift Idea with Low-Tech Charm
SPOILER ALERT: If your name is Paul or Patricia Roush and you live in Central Lake, MI, stop reading now or you’ll ruin one of the surprises under the Christmas tree this year. Really. You’ve been warned! Every year I put “Amazon gift certificate” on my holiday and birthday wish lists so that I can … Continue reading “Photo Books from Blurb: A High-Tech Gift Idea with Low-Tech Charm”
TST Media Receives $3,333,997 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8d753aab-694e-4c91-ad36-aefb19cd5b21&Preview=1 Date 11/30/2012 Company Name TST Media Mailing Address 1400 Van Buren Street NE Minneapolis, ME 55413 Company Description We design and create digital tools that empower organizations to engage their audience in meaningful ways. We strive to create experiences that encourage collaboration, sharing and connectivity. We take pride in our products … Continue reading “TST Media Receives $3,333,997 New Financing”
Rib-X Closes First Tranche of $67.5 Million Preferred Stock Financing
[Updated 11:21 a.m.] Rib-X Pharmaceuticals of New Haven, CT, said today that it closed the first tranche of a $67.5 million Series 2 preferred stock financing, with a second tranche expected to close by year end. The company says it will use the money to fund a Phase 3 clinical trial of delafloxacin, an antibiotic for … Continue reading “Rib-X Closes First Tranche of $67.5 Million Preferred Stock Financing”
“Pre-IPO” Acquia Lands Another $30M, Sees Sales Topping $56M
With so much focus on the rise of mobile devices, apps, and networks, it can be easy to forget that there’s still life left in the good old website, that basic element of the original Internet revolution. One of the companies proving that notion is Burlington, MA’s Acquia. Founded in 2007, Acquia offers a wide … Continue reading ““Pre-IPO” Acquia Lands Another $30M, Sees Sales Topping $56M”
Wavii Builds a Facebook-Style Feed for All the World’s News
After talking with the guys behind Wavii, a Seattle startup that has built a Facebook-style feed for all the world’s events, I had two somewhat conflicting impressions: Wavii is potentially good medicine for information overload, and at the same time another sign that this modern affliction has us tightly in its grasp. Wavii delivers a … Continue reading “Wavii Builds a Facebook-Style Feed for All the World’s News”
Meet VeeMe: The Virtual Agent Programmed to Think Like Me
Meet VeeMe, my “virtual me” that acts like me and reacts like me. I’ve written about him/me before (here and here). If you think VeeMe sounds creepy, I agree! But I think it will happen. I both fear it and hope for it. So far, the information revolution has consistently performed beyond our imaginations. Twenty … Continue reading “Meet VeeMe: The Virtual Agent Programmed to Think Like Me”
Acquia Obtains $30,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6e9f05f0-797a-479c-95a8-342b57c9817d&Preview=1 Date 11/29/2012 Company Name Acquia Mailing Address 25 Corporate Drive 4th Floor Burlington, MA 01803 Company Description Acquia is a new software company that will provide value-added software products and services for the Drupal web collaboration and publishing platform. Website http://www.acquia.com Transaction Type Venture Equity Transaction Amount $30,000,000 Transaction Round Undisclosed … Continue reading “Acquia Obtains $30,000,000 New Round”
Rib-X Pharmaceuticals Lands Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=46f40007-2620-4688-9594-89a1101cb132&Preview=1 Date 11/29/2012 Company Name Rib-X Pharmaceuticals Mailing Address 300 George Street New Haven, CT 06511 Company Description Rib-X Pharmaceuticals is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The company’s underlying drug discovery engine capitalizes on its proprietary high-resolution crystal … Continue reading “Rib-X Pharmaceuticals Lands Series B Financing Round”
P2 Science Garners $150,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e980c862-9f2a-4985-b8fa-5b721dbe4456&Preview=1 Date 11/29/2012 Company Name P2 Science Mailing Address 4 Science Park New Haven, CT 06511 Company Description The company is using patent pending technology from the Yale Center for Green Chemistry and Green Engineering to develop and manufacture a new class of high performance surfactants, C-glycosides (CG’s). CG’s find application in … Continue reading “P2 Science Garners $150,000 New Funding”
Nick Beim Jumps from Matrix Partners to Venrock
Boston-based venture capital firm Matrix Partners has lost its New York-based partner. Star investor Nick Beim, who had been with Matrix for 12 years and in New York for the firm since 2010, has joined Manhattan-based Venrock. A Venrock spokesperson says the firm is not commenting on Beim’s switch. But according to Beim’s Linkedin page, … Continue reading “Nick Beim Jumps from Matrix Partners to Venrock”
Ginger.io Gets $6.5M, Led by Khosla, to “Open Up” Data-Driven Healthcare
Vinod Khosla has strong opinions on everything from education to energy storage. And he’ll speak his mind. On the topic of healthcare innovation, the bigwig entrepreneur and investor recently said that 80 percent of doctors could be replaced by machines. So perhaps it’s no surprise that Khosla Ventures has just backed MIT health-tech startup Ginger.io, … Continue reading “Ginger.io Gets $6.5M, Led by Khosla, to “Open Up” Data-Driven Healthcare”
Boston Deals: Incentive Targeting, Nantero, A123, TransMedics & More
[Updated 2:30 pm] A flurry of Boston-area investment and acquisition news hitting our radar screens today: —Incentive Targeting, a startup that priovides Web-based behavioral marketing services for grocery stores, has been acquired by Google. The startup has now confirmed the news, but isn’t providing any details. We don’t have any numbers to put with the deal yet, but … Continue reading “Boston Deals: Incentive Targeting, Nantero, A123, TransMedics & More”
Healthcare in Transition: Agenda Live for Xconomy Forum Dec. 10
There are few things that touch our lives, and our economy, like healthcare. That’s why we are especially excited about the stellar lineup we have assembled for our Dec. 10 forum that will provide a first-hand, personal dimension to what’s happening in healthcare innovation. Keynote speakers include Bryan Sivak, CTO of the U.S. Department of … Continue reading “Healthcare in Transition: Agenda Live for Xconomy Forum Dec. 10”
Selecta in Development Deal with Sanofi Worth up to $900 Million
[Updated 11/28/12, 11:04 a.m.]Selecta Biosciences, one of the many startups to emerge from the lab of famed MIT bioengineer Robert Langer, reported today that it scored a development deal with Paris-based Sanofi (NYSE: [[ticker:SNY]]) that includes potential milestone payments of up to $300 million each for new drugs for three life-threatening allergies. The Watertown, MA-based startup … Continue reading “Selecta in Development Deal with Sanofi Worth up to $900 Million”
Big Pharma’s Role in Supporting the Life Science Innovation Ecosystem
The life sciences industry has been challenged over the last several years with an economic environment that is not conducive to breeding new innovation. While things are slowly improving, reports abound of fewer investments in life science start-ups and fewer active investors in the sector. Many new ideas aren’t being developed—because the financial climate can’t … Continue reading “Big Pharma’s Role in Supporting the Life Science Innovation Ecosystem”
Getabl Obtains $4,086,668 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6f8a8997-9a62-453b-ad9a-1a28d5470dbe&Preview=1 Date 11/28/2012 Company Name Getabl Mailing Address Undisclosed Boston, MA 02127 Company Description The company develops applications for real time deal seeking and assistance. Website Undisclosed Transaction Type Venture Equity Transaction Amount $4,086,668 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms Venture Investor Avalon … Continue reading “Getabl Obtains $4,086,668 New Round”
Ginger.io Secures $6,500,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eefb7f88-6d33-40c5-ae4f-348d53468344&Preview=1 Date 11/28/2012 Company Name Ginger.io Mailing Address One Cambridge Center Cambridge, MA 02139 Company Description Ginger.io provides healthcare and life sciences clients with insight into patient behavior using mobile phone sensors and other big data. Existing methodologies for collecting behavior data are sparse, subjective, and error prone, relying on patient self-reported … Continue reading “Ginger.io Secures $6,500,000 Series A Funding”
Nantero Lands $10,637,871 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bbc53f76-fcc8-4645-9e56-45764a144626&Preview=1 Date 11/28/2012 Company Name Nantero Mailing Address 25-E Olympia Avenue Woburn, MA 01801 Company Description Nantero is a nanotechnology company using carbon nanotubes for the development of next-generation semiconductor devices. Website http://www.nantero.com Transaction Type Venture Equity Transaction Amount $10,637,871 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory … Continue reading “Nantero Lands $10,637,871 New Financing Round”
Euthymics Bioscience Obtains $3,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=35cb54fa-4c3f-42a6-886d-9c1f9e23efbb&Preview=1 Date 11/28/2012 Company Name Euthymics Bioscience Mailing Address 43 Thorndike St. Cambridge, MA 02141 Company Description Euthymics Bioscience, Inc. is a neuroscience-focused clinical-stage company developing next-generation treatments for depression. Euthymics’ initial focus is on patients who do not respond adequately to SSRIs. EB-1010 for depression is expected to improve efficacy and … Continue reading “Euthymics Bioscience Obtains $3,000,000 New Round”
Wing Power Energy Lands $486,018 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=efd297ff-95d6-4a70-a9df-a9d7c1de45b2&Preview=1 Date 11/28/2012 Company Name Wing Power Energy Mailing Address 142 Canal Street Salem, MA 01970 Company Description Wing Power Energy’s new patented blade design is at the core of our industry changing performance, capturing the imagination of customers and investors alike. Our product innovations go beyond performance to encompass our customers’ … Continue reading “Wing Power Energy Lands $486,018 New Financing Round”
SchoolChapters Garners $309,506 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6c68cb26-2ce2-4507-bfc6-d3cb4a9b8b7e&Preview=1 Date 11/28/2012 Company Name SchoolChapters Mailing Address 45 South Main Street 302 West Hartford, CT 06107 Company Description SchoolChapters, Inc. was started by entrepreneurs focused on delivering innovative technology solutions for educators. Educators are the key to building a quality learning experience for our children. Website http://www.schoolchapters.com Transaction Type Debt Transaction … Continue reading “SchoolChapters Garners $309,506 New Round”
Google Acquires Incentive Targeting for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=252eed8f-1f3f-4f1b-882d-d758cdd94ab4&Preview=1 Date 11/28/2012 Company Name Incentive Targeting Mailing Address 196 Broadway First Floor Cambridge, MA 02139 Company Description Incentive Targeting partners with retail chains to provide a targeted marketing service to manufacturers of grocery and consumer products. Using our service, manufacturers market directly to individual shoppers across our entire retail network—based on … Continue reading “Google Acquires Incentive Targeting for Undisclosed Sum”
Pfizer Invests in Rhythm to Support Diabetes, Obesity Drug Programs
Boston-based Rhythm can move ahead with its experimental drugs for obesity and diabetes assured of a very deep-pocketed partner. The startup announced today that Pfizer Venture Investments, the venture capital arm of New York pharma giant Pfizer (NYSE: [[ticker:PFE]]), agreed to invest $8 million in the company, completing a $33 million Series B financing. That … Continue reading “Pfizer Invests in Rhythm to Support Diabetes, Obesity Drug Programs”
Open Source Entrepreneurship
One of the great things about being a retired entrepreneur is that I get to give back to the community that helped me. I assembled this collection of free and almost free tools, class syllabi, presentations, books, lectures, videos in the hope that it can make your path as an entrepreneur or educator easier. Free: … Continue reading “Open Source Entrepreneurship”
And the Global Capital of Robotics Is…Everywhere
Here at Xconomy we’ve spilled considerable ink over the question of why Silicon Valley robotics companies seem to lag behind their peers in big centers of robotics like Boston and Pittsburgh. But if you look at the locations of robot makers worldwide, it’s clear that no single region really dominates this emerging industry. Makers of … Continue reading “And the Global Capital of Robotics Is…Everywhere”
Gemvara CEO Matt Lauzon Steps Down: Thoughts on Startup Legacy and Future
Mr. Lauzon, we hardly knew ye. To some in the entrepreneurial community, you are a startup god. To others, you are a young Boston tech CEO who tweets too much. To me, you are a great story—and ultimately, perhaps, a greater loss. Matt Lauzon, the founder and chief executive of Boston-based online jeweler Gemvara, is … Continue reading “Gemvara CEO Matt Lauzon Steps Down: Thoughts on Startup Legacy and Future”
PowerInbox Merges with ActivePath, Looks to Push Interactive E-mail
What happens in Boston doesn’t always stay in Boston. Just ask Mark Zuckerberg, who famously moved Facebook from Harvard to Silicon Valley in 2004. But Matt Thazhmon, who wouldn’t mind overthrowing Zuck as the king of social, is playing things a little differently. His Cambridge, MA-based social e-mail startup, PowerInbox, is merging with New York-based … Continue reading “PowerInbox Merges with ActivePath, Looks to Push Interactive E-mail”
Does Jerusalem Have What It Takes to Build A Life Sciences Cluster?
Dark news was coming out of Israel on the morning of November 15. But in a talk that morning at MIT, Nir Barkat, mayor of Jerusalem, painted a bright picture of the city’s future. Barkat—whose name, incidentally, means “light”—argues that Jerusalem’s “brand name” has been building for over 3,000 years. As a panelist at the … Continue reading “Does Jerusalem Have What It Takes to Build A Life Sciences Cluster?”
Rhythm Pharmaceuticals Obtains $8,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=36cc698e-5fbd-4077-a423-286c318da9aa&Preview=1 Date 11/27/2012 Company Name Rhythm Pharmaceuticals Mailing Address 855 Boylston Street, 11th Floor Boston, MA 02116 Company Description Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Website http://www.rhythmtx.com Transaction Type Venture Equity Transaction Amount $8,000,000 Transaction Round Series B Proceeds Purposes Rhythm will use … Continue reading “Rhythm Pharmaceuticals Obtains $8,000,000 Series B Round”
PowerInbox Acquires ioRevolution for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=23340aa2-4be7-4256-a524-885b685be013&Preview=1 Date 11/27/2012 Company Name ioRevolution Mailing Address 129 Franklin Street Cambridge, MA 02139 Company Description The company has developed PowerInbox that allows any notification email from an outside website like Groupon or Facebook to be seen inside the body of your email, instead of having to click on a link in … Continue reading “PowerInbox Acquires ioRevolution for Undisclosed Sum”
Y Combinator Alters Investment Package to Avoid “Contested Divorces”
Startups admitted the Winter 2013 class at Y Combinator, the prestigious startup accelerator in Mountain View, CA, will be greeted by a smaller investment package. Under a new program outlined in a blog post today, startups will get $80,000 each from a group of four outside venture investors, in addition to Y Combinator’s investment of … Continue reading “Y Combinator Alters Investment Package to Avoid “Contested Divorces””
Writing Your First Android App
From General Assembly Boston: Info and registration here. Instructor: Morgan Bickle, Co-founder and CTO of Kinvey Thinking of launching an app in Android? This intermediate-level class will walk students through the process of building an Android app that goes a few steps beyond “Hello World”. Specifically, this class will cover: —Setting up a development environment … Continue reading “Writing Your First Android App”
The Art of Bootstrapping
With the entrepreneur population at an all-time high, venture capital is flowing faster than at any time since the dot-com boom In fact, in the second quarter of 2012, VCs participated in more than $2 billion in financing, which is the highest amount in the last five quarters. Yet, many startups fail despite VC funding … Continue reading “The Art of Bootstrapping”
The Few and the Proud: The Biotech Startup Class of 2012
[Updated: 3:35 pm PT, 12/3/12] Quick: Can you name three exciting biotech companies that got started, in your city, in 2012? I can’t, as a citizen of Seattle. Chances are, no matter where you live in the U.S., and no matter how plugged-in you are into the industry, you can’t either. This wasn’t supposed to … Continue reading “The Few and the Proud: The Biotech Startup Class of 2012”
Sproxil Secures $500,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=84677d91-a395-4730-b423-4b7cf04d7aca&Preview=1 Date 11/26/2012 Company Name Sproxil Mailing Address 1 Fitchburg Street Somerville, MA 02143 Company Description The company provides a mobile authentication system for identifying counterfeit medicine in developing countries. Website http://www.sproxil.com Transaction Type Debt Transaction Amount $500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A … Continue reading “Sproxil Secures $500,000 New Financing”
East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer
Alleged skullduggery by some New Jersey pharma execs, drug development pacts, and a European drug approval marked this holiday week on the East Coast. —The holiday-shortened week started out with an apparent crime caper right out of Law and Order. Three New Jersey-based pharma execs from Celgene (NASDAQ: [[ticker:CELG]]), Sanofi (NYSE: [[ticker:SNY]])and Stryker (NYSE: [[ticker:SYK]]) … Continue reading “East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer”
FluoroPharma Medical Secures $1,546,250 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e631565d-36bc-48fa-b712-306ebfa2390f&Preview=1 Date 11/23/2012 Company Name FluoroPharma Medical Mailing Address 500 Boylston Street Boston, MA 02116 Company Description FluoroPharma, Inc., a privately-held molecular imaging company headquartered in Boston MA, engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company’s initial focus is the development of breakthrough positron emission tomography … Continue reading “FluoroPharma Medical Secures $1,546,250 New Financing”
Healthrageous Obtains $1,280,540 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=28207ed2-a5e5-4203-ac11-42fcf6a1f5d2&Preview=1 Date 11/23/2012 Company Name Healthrageous Mailing Address 75 Federal St. Boston, MA 02110 Company Description The startup’s software is designed to automatically give people personalized advice to help them reach health goals such as losing weight, lowering blood pressure, or controlling their diabetes. Website http://www.Healthrageous.com Transaction Type Venture Equity Transaction Amount … Continue reading “Healthrageous Obtains $1,280,540 Series B Financing”
Swoop.com Garners $3,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7398f503-8fed-4362-95ce-61afcf811ce0&Preview=1 Date 11/22/2012 Company Name Swoop.com Mailing Address 125 Cambridgepark Drive Cambridge, MA 02140 Company Description Swoop is a Native Advertising service that seamlessly integrates relevant information about products and services – at times in the form of sponsored content or advertising – into the content that consumers are engaged with online. … Continue reading “Swoop.com Garners $3,000,000 Series B Round”
Boston Deals: Swoop, OwnCloud, Lookout Gaming, Streetwise Media
Updated 2:50 pm A buffet of small Boston-area fundraising items to whet your appetite as Turkey Day approaches: —Cambridge-based Swoop, a startup that offers what it calls “native” advertising to help Web publishers make money from their content, has raised $3 million of a financing round that could grow to $5 million, according to a … Continue reading “Boston Deals: Swoop, OwnCloud, Lookout Gaming, Streetwise Media”
ownCloud Obtains $2,449,999 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5378c7eb-a722-4421-8bb1-6bbfbd60d7b7&Preview=1 Date 11/21/2012 Company Name ownCloud Mailing Address 12 Foster Road Lexington, MA 02421 Company Description ownCloud gives you universal access to your files through a web interface or WebDAV. It also provides a platform to easily view & sync your contacts, calendars and bookmarks across all your devices and enables basic … Continue reading “ownCloud Obtains $2,449,999 New Funding Round”
TransMedics Obtains $36,150,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e22aa8f0-0573-438b-a488-aa4bcba8e7e9&Preview=1 Date 11/21/2012 Company Name TransMedics Mailing Address 200 Minuteman Road Andover, MA 01810 Company Description TransMedics has developed a revolutionary new system that enables living organ transplants. Website http://www.TransMedics.com Transaction Type Venture Equity Transaction Amount $36,150,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms … Continue reading “TransMedics Obtains $36,150,000 New Round”
Tokutek Receives $1,546,048 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=70edbe8b-4da7-499d-a857-e4cbec291b42&Preview=1 Date 11/21/2012 Company Name Tokutek Mailing Address 1 Militia Drive Lexington, MA 02421 Company Description Tokutek’s patent-pending technology is a result of ten years of research and development by experts in cache-oblivious algorithmics and is used to accelerate key database operations by orders of magnitude. Tokutek’s solution is based on a … Continue reading “Tokutek Receives $1,546,048 New Funding”
Innoveer Solutions Receives $2,660,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=22ffb3f7-066d-40ce-8703-ef58caf6755a&Preview=1 Date 11/21/2012 Company Name Innoveer Solutions Mailing Address 280 Summer Street 6th Floor Boston, MA 02210 Company Description Cloud CRM Technology & Business Process Experts Innoveer’s customers value us because of our industry-leading project success rate, flexible approach and the specialist point of view we bring to the table. Website http://www.innoveer.com … Continue reading “Innoveer Solutions Receives $2,660,000 New Financing Round”
General Catalyst Co-Founder John Simon Joins Sigma Prime
Updated at 5:30 pm John Simon, a veteran venture investor and entrepreneur, has found his next job: Managing director at Boston’s Sigma Prime Ventures. Simon was a co-founder at Cambridge-based General Catalyst Partners, but announced in July that he was leaving the firm after 12 years. Simon also has served as an executive at several companies, … Continue reading “General Catalyst Co-Founder John Simon Joins Sigma Prime”
NVCA Sponsoring 40 Startup Tickets for Mobile Madness NY on Dec. 4
The madness is nearly upon us…mobile madness, that is. We’re only two weeks away from Mobile Madness New York, a half-day forum filled with interactive talks with some of the top names in mobile computing and innovation, from Android co-inventor Rich Miner (now at Google Ventures) to Roger Ehrenberg of IA Ventures to Zarly co-founder … Continue reading “NVCA Sponsoring 40 Startup Tickets for Mobile Madness NY on Dec. 4”